Target intelligence / Profile preview

Beclin 2 (BECN2)

Target
BECN2
Molecular classification
Other, Autophagy regulator, Lysosomal trafficking regulator
01

Overview

Beclin 2 is a mammalian-specific member of the Beclin (BECN) family of autophagy regulators, encoded by the BECN2 gene. It participates in two mechanistically distinct lysosomal degradation pathways: canonical autophagy, and ligand-induced endolysosomal degradation of select G protein-coupled receptors (GPCRs) through interaction with the GPCR-associated sorting protein GASP1. In autophagy, Beclin 2 physically interacts with several proteins of the class III phosphoinositide 3-kinase (PI3K) complex and regulates the formation of autophagosomes. In endolysosomal trafficking, Beclin 2 controls the degradation of a subset of GPCRs, including δ-opioid and cannabinoid 1 receptors, a function not shared by its paralog Beclin 1. Genetic deletion of Beclin 2 in mice results in autophagy defects, altered GPCR turnover, increased food intake, obesity, and insulin resistance, highlighting a previously unrecognized link between autophagy, receptor sorting, and metabolic regulation[1][2][3].

Other names
BECN2BECN1P1
02

Biological functions

AutophagyLysosomal degradationG protein-coupled receptor (GPCR) catabolic processEndolysosomal traffickingGlucose metabolism
03

Disease associations

ObesityInsulin resistanceCancer (potential, due to autophagy role)Neurodegenerative disease (potential, via autophagy)Other
04

Safety considerations

Potential effects on glucose homeostasis, obesity, and insulin resistance if perturbed[1][2]

Beyond the preview

Go deeper on Beclin 2 (BECN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beclin 2 (BECN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call